Delaunoit Thierry, Neczyporenko Florence, Limburg Paul J, Erlichman Charles
Department of Oncology, Molecular Medicine Program, and Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Am J Gastroenterol. 2005 Mar;100(3):703-10. doi: 10.1111/j.1572-0241.2005.40605.x.
Small bowel adenocarcinoma (SBA) is a very rare entity accounting for one-fourth of the small intestine neoplasms. Usually accompanied by nonspecific symptoms occurring late in the course of the disease, they are associated with a dismal prognosis. It appears that SBA shares several genetic characteristics with large bowel tumors, but also has unique features. The purpose of this article is to review pathogenesis and risks factors of SBA to better understand its molecular features as well as its resemblances and dissimilarities with colorectal cancer (CRC). Better understanding of sporadic and hereditary genetic pathways potentially involved will undoubtedly lead to better prevention and therapeutic management of this rare but aggressive disease.
小肠腺癌(SBA)是一种非常罕见的疾病,占小肠肿瘤的四分之一。通常伴有疾病晚期出现的非特异性症状,其预后较差。SBA似乎与大肠肿瘤具有一些共同的遗传特征,但也有独特之处。本文旨在综述SBA的发病机制和危险因素,以便更好地了解其分子特征以及与结直肠癌(CRC)的异同。更好地理解可能涉及的散发性和遗传性遗传途径,无疑将有助于对这种罕见但侵袭性疾病进行更好的预防和治疗管理。